Skip to content

ALX ONCOLOGY HOLDINGS INC

ALXO

CIK 0001810182

← back to feed
Revenue (TTM)
$3.73M
Q1 May 2026
Net Income (TTM)
−$96.77M
+24.6% YoY Q1 May 2026
EPS Diluted (TTM)
−$1.65
+26.4% YoY Q1 May 2026
Gross Margin
—
Q1 May 2026
Operating Margin
-2,677.9%
Q1 May 2026
Net Margin
-2,592.4%
Q1 May 2026
Free Cash Flow (TTM)
−$110M
Q1 May 2026
Cash
$32.28M
Q1 May 2026
Total Debt
$8.51M
Q1 May 2026
Shares Outstanding
134.56M sh
Q1 May 2026

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings